The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

Knoxville-based New Day Diagnostics launched its blood test for colorectal cancer screening nationwide. ColoHealth will be available to order online or in-person with participating physicians. Around ...

Anne Jones, who is 51, is used to solving any problem that comes her way. She grew up on a farm in southeast Nebraska, where the humid summers and long, harsh winters made farming difficult. Jones was ...

If a blue-and-white box has arrived at your door, you’re not alone. Millions of adults across the U.S. now receive a use-at-home colorectal cancer screening test through their health insurance or ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your colon cancer ...

A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study. A noninvasive colorectal cancer screening ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved ...

Credit: Guardant. The Shield blood test for colorectal cancer screening is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood ...

Mainz Biomed N.V. has announced a partnership with Quest Diagnostics to commercialize its stool-based colorectal cancer screening test, ColoAlert, which detects tumor DNA to identify early-stage ...